JAMDA
Volume 7, Issue 9 , Pages 611-612 , November 2006

Randomized, Controlled Trials: Gold or bronze?

References 

  1. Dolinar RO, Leininger SL. Pay for performance means compliance-based care. JAm Med Dir Assoc. 2006;7:328–333
  2. Sackett DL, Rosenberg WMC, Gray JAM, et al. Evidence-based medicine: What it is and what it isn’t. BMJ. 1996;312:71–72
  3. Guyatt GH, Haynes B, Jaeschke RZ, et al. Users’ guides to the medical literature: XXV (Evidence-based medicine: Principles for applying the users’ guides to patient care). JAMA. 2000;284:1290–1296
  4. Schmucker DL, Vesell ES. Are the elderly underrepresented in clinical drug trials?. J Clin Pharmacol. 1999;39:1103–1108
  5. Messinger-Rapport BJ. Evidence-based medicine: Is it relevant to long-term care?. J Am Med Dir Assoc. 2004;5:328–332
  6. Le Quintrec JL, Bussy C, Golmard JL, et al. Randomized controlled drug trials on very elderly subjects: Descriptive and methodological analysis of trials published between 1990 and 2002 and comparison with trials on adults. J Gerontol Med Sci. 2005;60A:340–344
  7. Altman DG, Schulz KF, Mohr D, et al. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med. 2001;134:663–694
  8. Jüni P, Douglas DG, Egger M. Assessing the quality of controlled clinical trials. BMJ. 2001;323:42–46
  9. Gluud LL. Bias in clinical intervention research. Am J Epidemiol. 2006;163:493–501
  10. Guyatt GH, Sackett DL, Cook DJ Evidence-Based Medicine Working Group. Users’ guides to the medical literature, II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients?. JAMA. 1994;271:59–63
  11. Gross CP, Mallory R, Heiat A, Krumholz HM. Reporting the recruitment process in clinical trials: Who are these patients and how did they get there?. Ann Intern Med. 2002;137:10–16
  12. Britton A, McKee M, Black N, et al. Threats to applicability of randomized trials: Exclusions and selective participation. J Health Serv Res Policy. 1999;4:112–121
  13. Hall JC, Hall JL. Baseline comparisons in surgical trials. ANZ J Surg. 2002;72:567–569
  14. Egger M, Jüni P, Bartlet C CONSORT Group. Value of flow diagrams in reports of randomized controlled trials. JAMA. 2001;285:1996–1999
  15. Mulrow C, Lau J, Brand M. Pharmacotherapy for hypertension in the elderly. The Cochrane Database of Systemic Reviews. Available at: http://gateway2.ovid.com:80/ovidweb.cgi. Accessed July 16, 2004.
  16. Sanders C, Egger M, Donovan J, et al. Reporting on quality of life in randomized controlled trials: Bibliographic study. BMJ. 1998;317:1191–1194
  17. Fletcher RH. Evaluation of interventions. J Clin Epidemiol. 2002;55:1183–1190
  18. Godwin M, Ruhland L, Casson I, et al. Pragmatic controlled clinical trials in primary care: The struggle between external and internal validity. BMC Med Res Methodol. 2003;3:28–34
  19. Dickersin K, Rennie D. Registering clinical trials. JAMA. 2003;290:516–523
  20. Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ. 2004;170:477–480
  21. Boyd CM, Darer J, Bout C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases (Implications for pay for performance). JAMA. 2005;294:716–724
  22. Durso S. Using clinical guidelines designed for older adults with diabetes mellitus and complex health status. JAMA. 2006;295:1935–1940

PII: S1525-8610(06)00456-7

doi: 10.1016/j.jamda.2006.09.003

JAMDA
Volume 7, Issue 9 , Pages 611-612 , November 2006

Article Tools